Indiana Administrative Code › Title 410 - INDIANA DEPARTMENT OF HEALTH › Article 1 - COMMUNICABLE DISEASE CONTROL › Rule 2.5 - Disease Reporting and Control › Section 2.5-149 - Incorporation by reference

Current through July 10, 2024
Authority: IC 16-19-3-4; IC 16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 149.
(a) The
				following documents are hereby incorporated by reference into this rule:
(1) Centers for Disease Control and
				Prevention (CDC). Guideline for Isolation Precautions: Preventing Transmission
				of Infectious Agents in Healthcare Settings 2007. Siegel JD, Rhinehart E,
				Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory
				Committee (HICPAC); June 2007. Electronic copies of this publication are
				available at
http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf
.
(2) CDC. Case Definitions for Infectious
				Conditions Under Public Health Surveillance. Morbidity and Mortality Weekly
				Report (MMWR); May 2, 1997; Vol. 46; No. RR-10.
(3) CDC. 2012 Nationally Notifiable Diseases
				and Conditions and Current Case Definitions. Publication available from the CDC
				Office of Surveillance, Epidemiology and Laboratory Services, Division of
				Notifiable Diseases and Healthcare Information, 1600 Clifton Road, Atlanta,
				Georgia 30333. Electronic copies of this publication are available at
http://stacks.cdc.gov/view/cdc/12088/
.
(4) CDC. Guideline for Hand Hygiene in
				Health-Care Settings. Recommendations of the HICPAC and the
				HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR; October 25, 2002; Vol. 51;
				No. RR-16.
(5)
										45
				CFR 164.512 (2013).
(6) American Public Health Association
				(APHA). Control of Communicable Diseases Manual, 20th Edition. Heymann, DL,
				ed.; 2014. Publication available from the APHA, Publication Sales, P.O. Box
				933019, Atlanta, Georgia, 31193-3019. Electronic copies of this publication are
				available at
https://www.apha.org
.
(7) CDC. Sexually Transmitted Diseases
				Treatment Guidelines, 2010. MMWR; December 17, 2010; Vol. 59; No.
				RR-12.
(8) CDC. Guidelines for
				Preventing the Transmission of Mycobacterium tuberculosis in Health-Care
				Settings, 2005. MMWR; December 30, 2005; Vol. 54; No. RR-17.
(9) CDC. Treatment of Tuberculosis. American
				Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR; June
				20, 2003; Vol. 52; No. RR-11.
(10)
				CDC. Guidelines for the Investigation of Contacts of Persons with Infectious
				Tuberculosis. Recommendations from the National Tuberculosis Controllers
				Association and CDC. MMWR; December 16, 2005; Vol. 54; No. RR-15.
(11) Centers for Disease Control and
				Prevention guidelines, Recommendations for Use of an Isoniazid-Rifapentine
				Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis
				Infection. MMWR 2011; Volume 60, Pages 1650-1653. (12) American Academy of
				Pediatrics (AAP). Red Book: 2012 Report of the Committee on Infectious
				Diseases, 29th edition. Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds.;
				2012. Publication available from the AAP, 141 Northwest Point Boulevard, Elk
				Grove Village, Illinois, 60007-1098.
(13) CDC. Epidemiology and Prevention of
				Vaccine-Preventable Diseases. 12th Edition. Atkinson,W, Wolfe S, Hamborsky J,
				eds. Publication available from The Public Health Foundation, Publication
				Sales, P.O. Box 753, Waldorf, Maryland, 206040753.
(14) CDC. Manual for the Surveillance of
				Vaccine-Preventable Diseases. 5th Edition. Roush SW, McIntyre L, Baldy LM,
				eds.; 2012. Electronic copies of this publication are available at
http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
.
(15) CDC. Update to CDC's Sexually
				Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer
				a Recommended Treatment for Gonococcal Infections, 2012, MMWR; August 10, 2012;
				Vol. 61; No. 31; 590-594.
(16)
				World Health Organization (WHO). WHO Guidelines on Hand Hygiene in Health Care.
				WHO Press: Geneva, Switzerland, 2009.
(17) CDC. Revised definition for HIV
				Infection, as found in MMWR, Volume 63, Recommendations and Reports No. RR-03,
				April 11, 2014.